149 related articles for article (PubMed ID: 37953776)
21. [Relationship between Polymorphism of miR-155 and Its Target Gene MyD88 and Clinicopathological Features of Diffuse Large B-cell Lymphoma].
Li Y; Jia ZW; Kong XY; Cui GR; Liu XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):757-762. PubMed ID: 34105469
[TBL] [Abstract][Full Text] [Related]
22. Low expression of microRNA-146b-5p and microRNA-320d predicts poor outcome of large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone.
Wu PY; Zhang XD; Zhu J; Guo XY; Wang JF
Hum Pathol; 2014 Aug; 45(8):1664-73. PubMed ID: 24931464
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic regulation of miR-518a-5p-CCR6 feedback loop promotes both proliferation and invasion in diffuse large B cell lymphoma.
Huang Q; Zhang F; Fu H; Shen J
Epigenetics; 2021 Jan; 16(1):28-44. PubMed ID: 32600091
[TBL] [Abstract][Full Text] [Related]
24. MYD88 expression and L265P mutation in diffuse large B-cell lymphoma.
Choi JW; Kim Y; Lee JH; Kim YS
Hum Pathol; 2013 Jul; 44(7):1375-81. PubMed ID: 23380077
[TBL] [Abstract][Full Text] [Related]
25. Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases.
Dubois S; Viailly PJ; Bohers E; Bertrand P; Ruminy P; Marchand V; Maingonnat C; Mareschal S; Picquenot JM; Penther D; Jais JP; Tesson B; Peyrouze P; Figeac M; Desmots F; Fest T; Haioun C; Lamy T; Copie-Bergman C; Fabiani B; Delarue R; Peyrade F; André M; Ketterer N; Leroy K; Salles G; Molina TJ; Tilly H; Jardin F
Clin Cancer Res; 2017 May; 23(9):2232-2244. PubMed ID: 27923841
[No Abstract] [Full Text] [Related]
26. Primary testicular lymphoma demonstrates overexpression of the Wilms tumor 1 gene and different mRNA and miRNA expression profiles compared to nodal diffuse large B-cell lymphoma.
Mansoor A; Akhter A; Shabani-Rad MT; Deschenes J; Yilmaz A; Trpkov K; Stewart D
Hematol Oncol; 2023 Dec; 41(5):828-837. PubMed ID: 37291944
[TBL] [Abstract][Full Text] [Related]
27. Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling.
Turi M; Anilkumar Sithara A; Hofmanová L; Žihala D; Radhakrishnan D; Vdovin A; Knápková S; Ševčíková T; Chyra Z; Jelínek T; Šimíček M; Gullà A; Anderson KC; Hájek R; Hrdinka M
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982699
[TBL] [Abstract][Full Text] [Related]
28. mir-21-5p inhibits the progression of human chondrosarcoma by regulating CCR7/STAT3/NF-κB pathway.
Li G; Yang Y; Xu S; He M; Zhang Z
Connect Tissue Res; 2021 May; 62(3):313-324. PubMed ID: 31813289
[No Abstract] [Full Text] [Related]
29. miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-κB Signaling Pathway in Esophageal Squamous Cell Carcinoma.
Mei LL; Wang WJ; Qiu YT; Xie XF; Bai J; Shi ZZ
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28832500
[TBL] [Abstract][Full Text] [Related]
30. miR-145-5p exerts anti-tumor effects in diffuse large B-cell lymphoma by regulating S1PR1/STAT3/AKT pathway.
Gao Y; Ding X
Leuk Lymphoma; 2021 Aug; 62(8):1884-1891. PubMed ID: 33715582
[TBL] [Abstract][Full Text] [Related]
31. Circ_0003645 serves as miR-335-5p sponge to promote the biological process of diffuse large B-cell lymphoma by upregulating NFIB.
Lin D; Wang Y; Lei L; Lin C
Autoimmunity; 2022 Mar; 55(2):127-135. PubMed ID: 35001739
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-212-5p regulates the inflammatory response of periodontal ligament cells by targeting myeloid differentiation factor 88.
Hua B; Xiang J; Guo L; Lu D
Arch Oral Biol; 2020 Oct; 118():104831. PubMed ID: 32707140
[TBL] [Abstract][Full Text] [Related]
33. CircTBX5 knockdown modulates the miR-558/MyD88 axis to alleviate IL-1β-induced inflammation, apoptosis and extracellular matrix degradation in chondrocytes via inactivating the NF-κB signaling.
Wei W; Mu H; Cui Q; Yu P; Liu T; Wang T; Sheng L
J Orthop Surg Res; 2023 Jul; 18(1):477. PubMed ID: 37393232
[TBL] [Abstract][Full Text] [Related]
34. miR-140-5p is negatively correlated with proliferation, invasion, and tumorigenesis in malignant melanoma by targeting SOX4 via the Wnt/β-catenin and NF-κB cascades.
Zhao G; Yin Y; Zhao B
J Cell Physiol; 2020 Mar; 235(3):2161-2170. PubMed ID: 31385607
[TBL] [Abstract][Full Text] [Related]
35. Disrupting myddosome assembly in diffuse large B‑cell lymphoma cells using the MYD88 dimerization inhibitor ST2825.
Wang X; Tan Y; Huang Z; Huang N; Gao M; Zhou F; Hu J; Feng W
Oncol Rep; 2019 Nov; 42(5):1755-1766. PubMed ID: 31432184
[TBL] [Abstract][Full Text] [Related]
36. MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma.
Aggarwal V; Das A; Bal A; Srinivasan R; Das R; Prakash G; Malhotra P; Varma S
Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):311-318. PubMed ID: 29734251
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of miR-365a-3p relieves sepsis-induced acute myocardial injury by targeting MyD88/NF-κB pathway.
Lv H; Tian M; Hu P; Wang B; Yang L
Can J Physiol Pharmacol; 2021 Oct; 99(10):1007-1015. PubMed ID: 33852805
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-127-5p targets the biliverdin reductase B/nuclear factor-κB pathway to suppress cell growth in hepatocellular carcinoma cells.
Huan L; Bao C; Chen D; Li Y; Lian J; Ding J; Huang S; Liang L; He X
Cancer Sci; 2016 Mar; 107(3):258-66. PubMed ID: 26708147
[TBL] [Abstract][Full Text] [Related]
39. NF-κB p65 represses microRNA-124 transcription in diffuse large B-cell lymphoma.
Shim H; Nam J; Kim SW
Genes Genomics; 2020 May; 42(5):543-551. PubMed ID: 32207045
[TBL] [Abstract][Full Text] [Related]
40. Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions.
Meng Y; Quan L; Liu A
Gene; 2018 Feb; 642():205-211. PubMed ID: 29128636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
